Public Market Intelligence
Explore federally funded small business innovation research, technology awards, participating companies, and agency investments.
Company count, total reported award value are not available for this view.
Black Pearls Inc · National Science Foundation
Phase II1994$297,564
THE BLACK-LIP PEARL OYSTER, PINCTADA MARGARITIFERA, IS THE SOURCE OF RARE, VALUABLE BLACK PEARLS. CULTURE OF THIS SPECIES HAS PROVEN HIGHLY LUCRATIVE IN FRENCH POLYNESIA, WITH STRENGTHENING WORLDWIDE DEMAND. THE HAWAIIA…
Fziomed, Inc. · Department of Health and Human Services
Phase I1997$100,000
DESCRIPTION (Adapted from applicant's abstract): Adhesive disease is a significant problem in current medical practice. Implantable biomaterials, serving as barriers between healing serosal surfaces and fibrin clots, ar…
AFFINERGY, LLC · Department of Health and Human Services
Phase II2008$1,564,610
DESCRIPTION (provided by applicant): According to the National Institute of Dental and Craniofacial Research, 86% of adults over 70 years of age have at least moderate periodontitis with over a quarter having lost their…
Hemascience Laboratorytorie · Department of Health and Human Services
Phase I1984$49,048
N/A
BIOPANCREATE, INC. · Department of Health and Human Services
Phase I2012$168,530
DESCRIPTION (provided by applicant): The product that will result from the proposed SBIR program, a consortium collaboration between BioPancreate (a small business) and Cornell University, will be an orally-administered…
VIASAT, INC. · Department of Defense
Phase II1998$749,890
In many applications signal acquisition and data decoding must be carried out in the presence of unknown, possibly time-varying channel parameters. When the Signal-to-Noise Ration (SNR) is medium or rapidly varying, ad…
Syntro Corp. · Department of Defense
Phase I1983$49,980
N/A
INSECTIGEN INC · Department of Agriculture
Phase I2006$80,000
Bacillus thuringiensis (Bt) biopesticides are an environmentally safe alternative to chemical pesticides but less efficacious than chemical alternatives. The purpose of this study is to determine the suitability of BtBo…
X-L SYNERGY, LLC · Department of Health and Human Services
Phase I1991$50,000
THE PHASE I OBJECTIVE IS TO DESIGN A BIOFEEDBACK APPARATUS FOR THE HOME TREATMENT OF NOCTURNAL BRUXISM AND TO CONDUCT A PILOT STUDY ON ITS EFFECTIVENESS. THIS APPARATUS WILL CONSIST OF A BRUXISM SENSOR AND RADIO TRANSMI…
Hittman Materials And · Department of Energy
Phase I1984$49,000
N/A
EXTEMPO SYSTEMS, INC. · Department of Health and Human Services
Phase I2003$99,992
DESCRIPTION (provided by applicant): Brief interventions in primary care settings can reduce the high risks and costs of alcohol abuse. However, health care providers lack skills for effective intervention. Training the…
FOSTER-MILLER, INC. · Department of Defense
Phase I1995$70,000
Foster-Miller proposes an innovative approach to increase the frequency coverage of high temperature superconducting (HTS) antennas in the VHF/VHF frequency bands. We will concentrate on small antennas for missile seeke…
GLOBAL INFORMATION SYSTEMS TECHNOLOGY · Department of Defense
Phase I1986$50,000
N/A
INTEGRATED LABORATORY SYSTEMS, LLC · Department of Health and Human Services
Phase I1995$98,303
For the biomonitoring of DNA damage in aquatic species exposed to genotoxic agents, an optimal methbe capable of detecting many classes of DNA damage in a variety of cell types, should provide data aindividual cell, sho…
TECHNOLOGY MANAGEMENT INC · Department of Agriculture
Phase I1996$50,000
N/A
PHASE V PHARMACEUTICALS, INC. · Department of Health and Human Services
Phase I2005$100,000
DESCRIPTION (PROVIDED BY APPLICANT): Phase V Pharmaceuticals, Inc., develops lower cost alternatives for expensive drugs used in patients with central nervous system (CNS) injuries. The special needs of people with disa…
Kosan Biosciences, Inc. · Department of Health and Human Services
Phase I1998$100,000
N/A
Advanced Magnet Lab, Inc. · Department of Energy
Phase I1999$99,725
Not Available We propose to design, demonstrate and develop highly stable, single-mode vertical cavity surface emitting lasers (VCSELs) in 1 x N arrays (N > 8) operating at 1.3 ¿m at 1GHz bandwidths. Sensors Unlimited w…
MAGNIMED, INC. · Department of Health and Human Services
Phase I2003$206,810
DESCRIPTION (provided by applicant): Exciting recent developments in giant magnetorestrictive (GMS) and magnetic shape memory (MSM) material have led to the possibility of developing small, low-cost, room-temperature, h…
ANALYTIC DESIGNS INC · Department of Defense
Phase I1993$41,946
The scattering behavior for a collection of thousands of linear dipoles at resonance has long been a subject of study for passive electronic countermeasures (ECM) against pertinent threat radar systems. Previously, the…
BIOTEK, INC. · Department of Health and Human Services
Phase I1995$99,959
There is need for a convenient biodegradable bone substitute to support soft tissue and stimulate bWe will combine its unique BIOPORE material with the recently characterized osteogenic growth peptidthis objective. BIOP…
BIOPEPTIDES CORP · Department of Health and Human Services
Phase I2007$299,996
DESCRIPTION (provided by applicant): Lyme disease is caused by the spirochete Borrelia burgdorferi. This zoonosis is the most prevalent vector borne infectious disease in the United States and Europe and it continues to…
New England Research Institutes, Inc. · Department of Health and Human Services
Phase I1994$80,984
The research will develop a 20 to 30 minute state-of-the-science videotape that makes availableto newly diagnosed BPH patients information about benign prostatic hyperplasia (BPH), its causes,treatment and prevention. V…
Syntrix Biosystems, Inc. · Department of Health and Human Services
Phase I2003$163,329
DESCRIPTION (provided by applicant): Neutrophils are bloodborne inflammatory cells that exhibit potent oxidative and phagocytic activities. One important component of the neutrophils' role in the immune system is its ab…
PHYSICAL SCIENCES INC. · Department of Health and Human Services
Phase I2009$359,771
DESCRIPTION (provided by applicant): Response to carbidopa/levodopa (CD/LD), the most efficacious therapy in Parkinson's disease (PD), is often variable among patients. At initiation of therapy, some patients require hi…
See what leading AI assistants have to say about RFPCapture and CaptureIQ.
Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:
What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.